Healthy cardiac autonomic functioning (CAF) is essential for maintaining homeostasis in response to the environmental demands of everyday life. Impaired CAF is associated with higher morbidity and higher mortality. To explore CAF in survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) 1-10 years after transplant (median = 4.3 years), an ambulatory assessment was performed with 104 patients, and 45 age-and gender-matched healthy controls. Heart rate (HR) and respiratory sinus arrhythmia (RSA, that is, high-frequency HR variability) were measured in a laboratory setting and during a 12-hour naturalistic period of daily life. Cancer-related fatigue was assessed by the Functional Assessment of Chronic Illness -Fatigue questionnaire; physical fitness by bicycle-ergometry VO 2 max. In contrast to healthy controls, 4-year post-HSCT fatigue was greater in patients (P o 0.0001, Cohen's d effect size [d] = 1.14), and fitness was lower in patients (P o0.0001, d = 1.09). In both laboratory and real-life ambulatory conditions, average HR was persistently higher (P o0.0001, d = 0.88) and mean RSA magnitude lower (P o0.001, d = 0.69) among patients, compared with controls. Severely fatigued patients showed higher HR and lower parasympathetic cardiac control than nonfatigued patients (HR: P = 0.02, d = 0.47; RSA: P = 0.02, d = 0.72), and this was unrelated to fitness. These findings may have important implications for predicting long-term treatment outcome and consequences for routine post-HSCT care.
INTRODUCTION
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an established, effective treatment for malignant diseases of hemato-and lymphopoiesis. Nevertheless, recent progress in reducing transplant-related mortality 1 justify the broadening of focus from consideration of mere survival to more refined evaluation of risk factors and quality of life. 2 Little is known about alterations and patient outcomes, such as subclinical cardiac dysfunction, 3 risk of late cardiovascular events, 3, 4 post-treatment cancer-related fatigue (CRF) 5, 6 and depression. [7] [8] [9] [10] A pattern of tachycardia and attenuated parasympathetic cardiac control was observed in patients with Hodgkin's disease after radiation therapy 11 and has also been indicated in autonomic neuropathy associated with neurotoxic anthracycline chemotherapy for a variety of neoplastic malignancies. [12] [13] [14] [15] [16] In addition, general autonomic dysfunction was found in 50-63% of patients with advanced cancer [17] [18] [19] and may be predictive of reduced survival time. 20 We could find no previous investigations that specifically examined cardiac autonomic control among allo-HSCT survivors, despite the substantially increased risk among these patients for late adverse cardiovascular events. 3, 4 Chronic CRF is one of the most common and debilitating symptoms after cancer therapy, which can persist long after the treatment. [21] [22] [23] Several factors have been suggested as involved in CRF, [24] [25] [26] [27] for example, pro-inflammatory cytokine patterns, endocrinal dysfunction, anemia, pain and psychological distress. However, biological causes have not been well established, and the contribution of autonomic dysfunction to the development and course of CRF has rarely been investigated. Nevertheless, research on fatigue in non-cancer populations [28] [29] [30] and findings among breast cancer survivors 5, 6 do suggest a relationship between CRF and cardiac autonomic function.
Our study explores autonomic function in allo-HSCT long-term survivors, as well as possible relations between autonomic dysfunction and CRF in this population. We conducted an ambulatory assessment among 104 patients, 1-10 years post allo-HSCT, and 45 age-and gender-matched healthy controls. Heart rate (HR), respiration and accelerometry-assessed motor activity were concurrently monitored in a standardized laboratory setting (LAB), as well as during naturalistic conditions of daily life (DL). Respiratory sinus arrhythmia (RSA; that is, high-frequency HR variability) was employed as measure of parasympathetic cardiac control. 31, 32 Moreover, due to the influence of aerobic fitness upon HR and RSA, 33, 34 we assessed and statistically controlled for fitness, a control not commonly performed in previous studies of HR variability among allo-HSCT patients.
SUBJECTS AND METHODS Participants
Patients. Patients were selected from the transplant database of the hematology department of the University Hospital of Basel, Switzerland, according to following inclusion criteria: (1) the most recent transplant was allogeneic and received 1-10 years previously, (2) patients were in remission from cancer since transplantation, (3) their age range was 18-65 years and (4) they were fluent in German. Figure 1 illustrates the patients' enrollment process. 152 patients met the criteria within the recruitment time frame, and 104 enrolled for the study. Twenty-seven participated only by filling out the questionnaires and allowing use of their medical data. Seventy-seven patients agreed to the ambulatory assessment and completed at least the LAB measurements. Two DL data sets were lost due to equipment failure or non-compliance. Patients did not receive monetary incentive, but travel expenses were reimbursed whenever the appointment was scheduled separately from a regular appointment.
Disease-related information is assembled in Table 1 . Patients were generally transplanted in remission; remission induction was by standard therapy such as anthracycline and cytosine arabinoside followed by highdose cytosine arabinoside in a second cycle for patients with AML, and multiagent chemotherapy for patients with ALL. Patients with aplastic anemia and CML were generally not pretreated by chemotherapy; in more recent years CML patients had failed tyrosine kinase treatment. Patients with lymphoma had had multiagent chemotherapy including anthracycline, often VCR and alklylating agents in combination with monoclonal antibodies, that is, rituximab in the case of B-cell lymphoma. The conditioning regimen of patients' latest allo-HSCT are listed in Supplementary Table 1. Patients were assessed pretransplant by echocardiography to have normal cardiac function. Patients were generally not on cardiac medication such as beta-blockers and so on. Most commonly calcium channel blockers, diuretics and angiotensin converting enzyme inhibitors were used for cyclosporine-induced hypertension. Patients on beta-blockers are detailed in Supplementary Table 2 .
Control group. Inclusion criteria for the control group were (1) age between18 and 65 years, (2) good reported current health and no history of serious disease (for example, cancer, cardiovascular disease, diabetes and airway disorders) and (3) fluency in German. Forty-five healthy subjects, recruited from hospital personnel and elsewhere, formed an ageand gender-matched control group. These participants received a small monetary incentive, and travel expenses were refunded.
All participants were briefed about the study before the assessment day and informed consent was completed. The study was approved by the Ethics Commission of Both Basels, Switzerland.
Measures
Patients' current medical data, for example, diagnosis, treatment-related data and grade of chronic GvHD (cGvHD, NIH consensus 2005) 35 were obtained from hospital patient records and examination reports that were closest to the day of assessment. CRF was assessed with the validated German version of the Functional Assessment of Chronic Illness -Fatigue (FACIT-F) fatigue questionnaire (version 4).
36
Physical fitness-VO 2 max. Aerobic capacity (VO 2 max, mL/kg/min) as indicator for physical fitness) was estimated by means of a submaximal Astrand-Rhyming bicycle ergometer test. 37 Accordingly, VO 2 max is calculated from steady-state HR after 6 min of cycling with 60 cycles per minute under a defined workload. 38 Ambulatory monitoring data. Cardiovascular, respiratory and accelerometry data were monitored using the LifeShirt system (VivoMetrics, Ventura, CA, USA), 39, 40 which measures respiratory timing and volume parameters by two respiratory inductive plethysmography bands (200 Hz sample rate) at the ribcage and abdominal. A three-electrode electrocardiogram was registered (200 Hz) and movement activity was assessed by a three-axis accelerometer located at the sternum (50 Hz).
Raw data conversion and parameter calculation of the ambulatory data were performed using VivoLogic software (VivoMetrics), which was also employed for electrocardiogram artifact control and interpolated correction. The parameters assessed were HR (b.p.m.), RSA (ln ms; a measure of high-frequency HR variability), 32 tidal volume (V t , mL), breathing frequency (F b , br/min), minute ventilation volume (V m , l/min) and sum signal of threeaxis accelerometry.
Accelerometry units were calibrated to walking speed (cAcc, m/s). Tidal volume was calibrated for each subject against a portable ultrasonic spirometer (EasyOne, NDD Medical Technologies, Zürich, Switzerland). 41, 42 Median minute values of these parameters were exported for offline data cleaning, reduction and statistical analyses.
Respiratory measures (V t and F b ) may confound the assessment of RSA as index of cardiac vagal tone. 43, 44 To ensure that group differences in RSA adequately reflect variations in cardiac vagal tone, respiratory parameters need to be similar between groups within compared situations. We found no differences in these measures between groups. Abbreviations: AA = aplastic anemia; AID = autoimmune disease; g/L = grams per liter; MDS = myelodisplastic syndrome; MH = Hodgkin's disease; MPS = myeloproliferative syndrome; NHL = non-Hodgkin lymphoma; PCD = plasma cell disorder.
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Procedure. All subjects first completed the FACIT-F fatigue questionnaire and performed the submaximal fitness test. Subsequently, they were equipped with the LifeShirt gear and underwent the following protocol in the laboratory (LAB) aimed to standardize common real-life situations: sitting quietly on a chair (SIT, 5 min); casually speaking to the laboratory investigator about a topic of their choice seated (SPEAK, 3 min); quietly standing (STAND, 3 min); and reading quietly while seated (READ, 5 min). An interval of a minimum of 20 min between end of the fitness test and beginning of the standardized protocol was used as a recovery phase. After the LAB assessment, participants were requested to proceed to their regular, everyday life and wore the LifeShirt for the next 24 h. We present here the data from the standard protocol and the awake hour period (from 0900 to 2100 hours) of the ambulatory assessment that reflects active DL. Sleep data will be presented in another paper.
Data analysis
Group differences in demographic variables, CRF and VO 2 max were tested using Student's T-tests, Mann-Whitney U-tests 45 and Pearson χ 2 -tests, whenever appropriate. Where differences in variances were found too big between groups, T-tests with separate variance estimate were conducted (Welch's T-test). Two-sided significance level was Po 0.05. Power calculations were calculated from independent T-test estimation, for the two major variables, RSA and HR, based upon a minimum power of 0.80, an expected Cohen's d effect size of 0.60 and P-value of 0.025 (to adjust for two variables being assessed as outcome measures). The minimum N's for patient and control groups were 73 and 43, respectively. The actually achieved power for these measures was 0.92 and 0.99, based on the final results. Other results were not assessed for power nor corrected for multiple comparisons, due to the exploratory nature of analyses (for example, group differences in fatigue and VO 2 max, as well as withinpatient analyses and adjustments for VO 2 max).
The physiological variables under the LAB conditions and during DL were analyzed by means of a general linear model (GLM), multivariate, repeated measures analysis of variance. The GLM for the standard protocol comprised two levels for GROUP and four levels of repeated measures for the conditions (COND): SIT, STAND, SPEAK and READ. To evaluate patterns across awake daytime (from 0900 to 2100 hours), the ambulatory data were segmented into four times of day forming a four-level, within-subject factor of time of day (TOD). Each level was the average of 3 hours: Morning from 0900 hours, midday from 1200 hours, afternoon from 1500 hours and evening from 1800 hours. The GLM for daytime analyses also comprised a GROUP (allo-HSCT vs healthy controls) × within-subject (TOD) multivariate repeated measures analysis. For interpretation of interaction effects, post-hoc testing was performed by contrasts of simple main effects.
The two groups were age-and gender-matched by design. VO 2 max was introduced in secondary analyses as covariate into the GLM to account for the influence of aerobic capacity on HR and RSA. For the analyses, RSA and VO 2 max values were natural logarithm transformed.
Relations between CRF and autonomic measures among patients were examined by an analysis of the tertile split of FACIT-FS scores among patients into three approximately equally sized groups: clinically high (N = 28; scores = 0-36); medium (N = 22; scores = 37-46); and non-fatigue (N = 25; scores = 47-52). Differences in 12-hour daytime averages (from 0900 to 2100 hours) of cardiovascular variables between the three patients groups were analyzed by GLM with VO 2 max as covariate and tested by orthogonal contrast analysis. Group sizes for the analysis vary depending on the availability of data after artifact control.
RESULTS

Demographics and sample characteristics
Demographic characteristics of patients and controls are presented in Table 2 . Groups did not differ in gender, age, marital status, employment status, body mass index or smoking habit. Education level was higher for controls (Mann-Whitney Test: U = 1652.5; P = 0.003).
The distribution of diagnoses and treatment modalities in the patient sample was heterogeneous. Table 1 shows the proportions of disease classes and conditioning regimen among patients, as well as cGvHD grade and hemoglobin levels at the time of assessment. Patients' median time since transplant was 4.3 years (range: 1-11).
Fatigue and physical fitness After a median duration of 4.3 years post transplant, patients reported significantly greater fatigue than healthy controls (t = 7.63; P o 0.0001; d = 1.14); see Table 2 . Two-thirds of the patients manifested moderate-to-severe fatigue; one-third reported severe fatigue. In addition, VO 2 max measures (Table 3) indicated that the patients were significantly less physically fit than controls (F = 33.63; P o0.0001; d = 1.09).
Physiological measures
Measures of physical activity and respiration. All results for ambulatory LAB and DL conditions are provided in Table 3 . Accelerometry-measured, calibrated physical activity (cAcc) was Relations between fatigue and autonomic measures. A GLM analysis of HR and RSA was performed with patients grouped by tertiles of fatigue scores (HFP; clinically high-fatigued patients; MFP, medium-fatigued patients; NFP, non-fatigued patients; and CTL, controls). The GLM was significant for both, HR (F = 9.04; Po 0.0001) and RSA (F = 6.57; P o 0.001; see Table 4 ), whereas activity and respiratory parameters during DL were comparable in all groups.
As shown by contrast analysis employing NFP as reference group (see Figure 3 and Table 5 ), HR was higher in the HFP than in the NFP (t = 2.42; P = 0.02; d = 0.69), and RSA was lower in HFP than in NFP (t = − 2.39; P = 0.02; d = 0.72). No difference was found between NFP and CTL, although there was a trend for HR (t = 1.87; P = 0.06; d = 0.47), as well as a trend for the difference between NFP and MFP for both variables (HR: t = 1.88; P = 0.06; d = 0.55; RSA: t = − 1.78; P = 0.08; d = 0.56).
Because fitness and cardiac autonomic function are related, we controlled each variable for VO 2 max. Both GLMs remained significant, HR (F = 4.59; P = 0.005) and RSA (F = 3.44; P = 0.02); see Table 4 . The corresponding contrast analysis (see Table 5 ) showed increased significance in the HFP vs NFP for each measure, and greater effect size (HR: t = 2.68, P = 0.008, d = 0.70; RSA: t = -2.74, P = 0.007, d = 0.72). The trend in both dependent variables remained for MFP vs NFP (HR: t = − 1.83, P = 0.07, RSA: t = − 1.89, P = 0.06), and no differences between LFP and CTL were found.
The findings remained similar when comparisons were made with patients without the following comorbidities: chronic kidney disease, diabetes, polyneuropathy, hyperlipidemia, hypertension and coronary heart disease. Frequencies among patients can be found in Supplementary Table 3 .
DISCUSSION
We examined autonomic regulation among allo-HSCT patients, compared with healthy control participants, by analysis of HR and RSA, an index of parasympathetic cardiac control. Measurements were made both under naturalistic conditions of daily activity and during a standardized set of laboratory conditions aimed at approximating common daily activities in a controlled manner.
HR was persistently higher and RSA lower among patients, and patients exhibited blunted patterns of HR and RSA dynamics over the day. These findings were found, although levels and patterns of motor activity and metabolic demand (as measured by accelerometry and V m ) were comparable among patients and controls. In addition, patients, in contrast to controls, exhibited reported substantially more fatigue and markedly poorer physical fitness still after an average of 4 years post transplantation.
After adjusting HR and RSA for the influence of fitness, the differences between groups were reduced but remained significant for HR. This suggests that variations in physical fitness may at least partially be responsible for group differences in cardiac autonomic control. However the causal relationship between autonomic control and fitness remains unclear (for example, is fitness among patients reduced because of impaired cardiovascular autonomic control, or the reverse?).
We also found higher HR and attenuated RSA among highly fatigued patients in comparison with both non-fatigued patients and healthy controls, and this effect persisted even after statistical control for fitness. This suggests that cardiovascular autonomic mechanisms may contribute to sustained, long-term CRF. These results are also supported by another study 5 that found elevated norepinephrine levels of unknown origin and diminished HR variability in highly fatigued post-treatment breast cancer patients. Nevertheless, this association between fatigue and autonomic control is preliminary and requires further investigation under more thorough experimental control.
Previous findings of long-lasting tachycardia and cardiac autonomic dysfunction among breast cancer patients who had previously undergone anthracycline chemotherapy 12, 16 suggest a possible role of drug toxicity in allo-HSCT, which may affect neuronal autonomic pathways, as well as cardiac and arterial morphology. This appears plausible, since patients undergoing allo-HSCT are exposed to high cumulative doses of chemotherapy. [46] [47] [48] The impact of persistent autonomic dysregulation on the posttransplant adaptation process in allo-HSCT survivors requires future longitudinal investigation, for example, in exercise training studies that examine effects of different pre-training levels of autonomic function upon improvement in fitness and other measures of health. In addition, our results suggest the possible utility of estimation of subclinical levels of cardiac autonomic impairment for prediction of future cardiovascular risk in this Abbreviations: b.p.m. = beats/min; CI = confidence interval; CTL = controls; HFP = clinically high-fatigued patients; HR = heart rate; ln mL/kg/min = natural logarithm of milliliters per kilogram per minute; ln ms = natural logarithm of milliseconds; MFP = medium-fatigued patients; NFP = non-fatigued patients; RSA = respiratory sinus arrhythmia; VO 2 max = aerobic capacity.
a Least squares marginal means adjusted for VO 2 max.
Cardiac autonomic functioning after allo-HSCT G Deuring et al patient population, especially because the cumulative incidence of late cardiovascular accidents is high among allo-HSCT patients, estimated between 4 and 17%. 3, 4 Our study provides evidence about the cardiovascular functioning of allo-HSCT survivors during ecologically valid, real-life conditions, consistently supported by findings of the standardized laboratory protocol. Furthermore, the assessment of aerobic capacity to quantify physical fitness provides additional useful information and, in our opinion, should be seriously considered for future studies on HR variability.
Regarding limitations, our sample was a particular subset of allo-HSCT patients, for example, only including those in current remission. Other biomedical inclusion criteria and the unavoidable self-selection of patients for the study are factors that limit the generalizability of our results. In addition, all patients were recruited from a single institution, and we employed a convenience control sample of healthy individuals who were largely recruited among employees of the University Hospital. Because of the exploratory nature of this study, we also did not apply corrections for multiple testing. Finally, a cross-sectional design cannot provide proof of causal relationships. Despite these caveats, we believe that our findings provide new evidence regarding long-term effects of allo-HSCT upon fatigue, physical fitness and cardiovascular control, as well as a plausible association between CRF and autonomic control among allo-HSCT survivors. Further future research would appear warranted. Tables 4 and 5 . Whiskers indicate 95% confidence intervals. b.p.m. = beats/min; CTL = controls; HPF = clinically high-fatigued patients; ln ms = natural logarithm of milliseconds; MFP = medium-fatigued patients; NFP = non-fatigued patients. Abbreviations: b.p.m. = beats/min; CI = confidence interval; CTL = controls; d = Cohen's d effect size; DL = active daily life ambulatory assessment; HPF = clinically high-fatigued patients; HR = heart rate; ln mL/kg/min = natural logarithm of milliliters per kilogram per minute; ln ms = natural logarithm of milliseconds; MFP = medium-fatigued patients; NFP = non-fatigued patients; RSA = respiratory sinus arrhythmia; VO 2 max = aerobic capacity. a Negative estimate signifies lower mean than NFP.
